Skip to content

The effect of adding the transforaminal epidural block to percutaneous laser disc decompression s

The effect of adding the transforaminal epidural block to percutaneous laser disc decompression on the level of disability in everyday life, pain perception, and nerve root irritation of patients with herniated discs

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20230518058225N6
Enrollment
60
Registered
2024-10-10
Start date
2024-10-16
Completion date
Unknown
Last updated
2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Herniated discs. Other intervertebral disc disorders

Interventions

Intervention 1: Intervention group: By injecting 1 mg of midazolam (with a concentration of 1 mg per cc - manufacturer: Aburihan Pharmaceutical Company) and 50 micrograms of fentanyl (concentration of

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 70 Years

Inclusion criteria

Inclusion criteria: The age range from 30 to 70 years. Proven lumbar disc level one to three A person with normal health A person with mild systemic disease A person with a severe systemic disease that threatens the patient's life The patient must have unilateral pain for at least three months and has not responded to drug treatment Do not have a history of any surgical intervention to treat the desired disc The decrease in disc height in them should be less than 50%

Exclusion criteria

Exclusion criteria: Infection Bleeding disorders Neurological diseases Neurological disorders Drug sensitivity Psychiatric diseases

Design outcomes

Primary

MeasureTime frame
Amount of pain medication received. Timepoint: 2 weeks, 2 months and 3 months after surgery. Method of measurement: Based on the patient's statement.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNakta Davoudi

Iran University of Medical Sciences

naktadavoodi_ib@yahoo.com+98 21 6435 2222

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026